Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mefloquine vs Sulfadoxine-Pyrimethamine for Malaria Prevention in Pregnancy
NCT00274235Phase 3Completed
- Sponsor
- Institut de Recherche pour le Développement
- Start
- Jul 2005
- Primary completion
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of mefloquine in malaria, sponsored by Institut de Recherche pour le Développement. Started Jul 2005; status: completed.
02
Drugs
mefloquine
03
Conditions
malaria
Beyond the preview
Go deeper on NCT00274235.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00274235.